Objective Although the significance of increased plasma D-dimer levels in activating
coagulation and fibrinolysis has been reported, it is still controversial whether it can be used …

Background Hypercoagulability in lung cancer patients is associated with a high incidence
of mortality and morbidity in the world. Therefore, this meta‐analysis aimed to explore the …

There are great expectations for artificial intelligence (AI) in medicine. We aimed to develop
an AI prognostic model for surgically resected non-small cell lung cancer (NSCLC). This …

Background Coagulation and fibrinolysis activation is frequently observed in cancer
patients, and the tumors in these cases are thought to be associated with a higher risk of …

Background: Complications of coronavirus disease 2019 (COVID-19) include coagulopathy.
We performed a meta-analysis on the association of COVID-19 severity with changes in …

Background: Invasive ductal carcinoma (IDC) is the most common type of metastatic breast
cancer. Due to the lack of valuable molecular biomarkers, the diagnosis and prognosis of …

OBJECTIVES Early-stage lung adenocarcinoma (ADC) has a great heterogeneity in
prognosis that is difficult to evaluate effectively. Thus, we developed and validated an …

Purpose Elevated plasma fibrinogen and D-dimer levels indicate activation of hemostasis
and fibrinolysis, and this activation is required for tumor angiogenesis, metastasis, and …

Systemic inflammation and activation of haemostasis are common in patients with lung
cancer. Both conditions support tumour growth and metastasis. Therefore, inflammatory and …

Activation of blood coagulation contributes to cancer progression. Tissue factor pathway
inhibitor‐1 (TFPI‐1) is the main inhibitor of extrinsic coagulation pathway. The aim of this …